12-19439805-C-G
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The ENST00000266508.14(AEBP2):āc.106C>Gā(p.Pro36Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000887 in 1,510,814 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
ENST00000266508.14 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
AEBP2 | NM_153207.5 | c.106C>G | p.Pro36Ala | missense_variant | 1/8 | ENST00000266508.14 | NP_694939.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
AEBP2 | ENST00000266508.14 | c.106C>G | p.Pro36Ala | missense_variant | 1/8 | 1 | NM_153207.5 | ENSP00000266508 | ||
AEBP2 | ENST00000398864.7 | c.106C>G | p.Pro36Ala | missense_variant | 1/9 | 1 | ENSP00000381840 | P1 | ||
AEBP2 | ENST00000538425.5 | c.-16-22705C>G | intron_variant | 4 | ENSP00000444255 | |||||
AEBP2 | ENST00000541908.5 | c.-16-22705C>G | intron_variant | 3 | ENSP00000437983 |
Frequencies
GnomAD3 genomes AF: 0.000535 AC: 81AN: 151440Hom.: 1 Cov.: 32
GnomAD3 exomes AF: 0.0000770 AC: 8AN: 103870Hom.: 0 AF XY: 0.0000515 AC XY: 3AN XY: 58308
GnomAD4 exome AF: 0.0000390 AC: 53AN: 1359260Hom.: 0 Cov.: 36 AF XY: 0.0000462 AC XY: 31AN XY: 670562
GnomAD4 genome AF: 0.000534 AC: 81AN: 151554Hom.: 1 Cov.: 32 AF XY: 0.000446 AC XY: 33AN XY: 74072
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 09, 2022 | The c.106C>G (p.P36A) alteration is located in exon 1 (coding exon 1) of the AEBP2 gene. This alteration results from a C to G substitution at nucleotide position 106, causing the proline (P) at amino acid position 36 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at